Levocarnitine Clinical Trials
3 recruitingDietary Supplement
Early Phase 12Phase 31
Showing 1–3 of 3 trials
Recruiting
Early Phase 1
Oral Carnitine in Heart Failure Patients
Heart FailureCarnitine Deficiency
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's20 enrolled1 locationNCT07201714
Recruiting
Phase 3
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
Mixed Phenotype Acute LeukemiaLymphoblastic LymphomaB Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1+3 more
Children's Oncology Group440 enrolled229 locationsNCT05602194
Recruiting
Early Phase 1
Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia
Acute Lymphoblastic LeukemiaHepatotoxicity
Children's Hospital of Orange County20 enrolled2 locationsNCT05501899